Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMJ Case Rep. 2011 May 3;2011. pii: bcr1220103599. doi: 10.1136/bcr.12.2010.3599.

High-dose intravenous immunoglobulins: a promising therapeutic approach for idiopathic systemic capillary leak syndrome.

Author information

  • 1Department of General Internal Medicine, Inselspital Bern, University Hospital Bern, Bern, Switzerland.

Abstract

The systemic capillary leak syndrome (SCLS), also known as Clarkson's disease, is a life-threatening disorder of unknown cause. It is characterised by recurrent acute episodes of hypotension, weight gain and generalised oedema with haemoconcentration and hypoproteinaemia caused by paroxysmal capillary hyperpermeability with a shift of plasma fluid from the intravascular to the interstitial space. We report the case of a 40-year-old woman with chronic SCLS treated with high-dose intravenous immunoglobulins, after a prophylactic therapy with theophylline and terbutaline was poorly tolerated and failed to decrease the frequency and severity of the attacks sufficiently.

PMID:
22696704
[PubMed - indexed for MEDLINE]
PMCID:
PMC3089932
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk